The Importance of Aquaporin-4 Antibody Assays in Patients beyond the Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders
Päätekijät: | Sato, D, Nakashima, I, Takahashi, T, Misu, T, Waters, P, Kuroda, H, Nishiyama, S, Suzuki, C, Takai, Y, Itoyama, Y, Fujihara, K, Aoki, M |
---|---|
Aineistotyyppi: | Journal article |
Julkaistu: |
2013
|
Samankaltaisia teoksia
-
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Tekijä: Sato, D, et al.
Julkaistu: (2013) -
Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
Tekijä: Sato, D, et al.
Julkaistu: (2014) -
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Tekijä: Nour, M, et al.
Julkaistu: (2015) -
Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders
Tekijä: Yoshiki Takai, et al.
Julkaistu: (2023-07-01) -
CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder
Tekijä: Chihiro Namatame, et al.
Julkaistu: (2021-01-01)